Page last updated: 2024-09-04

docetaxel anhydrous and thiacremonone

docetaxel anhydrous has been researched along with thiacremonone in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (thiacremonone)	Trials (thiacremonone)	Recent Studies (post-2010) (thiacremonone)
12,110	3,216	6,920	10	0	7

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ban, JO; Han, SB; Hong, JT; Hwang, BY; Jeong, HS; Lee, HS; Moon, DC; Song, S; Yoon, DY	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and thiacremonone

Article	Year
Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B. Molecular cancer research : MCR, 2009, Volume: 7, Issue:6 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Taxoids; Thiophenes; Xenograft Model Antitumor Assays	2009

Article

Year

Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.

Molecular cancer research : MCR, 2009, Volume: 7, Issue:6

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Taxoids; Thiophenes; Xenograft Model Antitumor Assays

2009